Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Schizophrenia Research|June 7, 2008
Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1Jonathan M Meyer, Vicki G Davis, Joseph P McEvoy, et al.
Journal of Latina/O Psychology|November 15, 2016
Machismo, Marianismo, and Negative Cognitive-Emotional Factors: Findings From the Hispanic Community Health Study/Study of Latinos Sociocultural Ancillary StudyAlicia Nuñez, Patricia González, Gregory A Talavera, et al.
Schizophrenia Research|September 9, 2008
Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia studyGail L Daumit, Donald C Goff, Jonathan M Meyer, et al.
The American Journal of Psychiatry|March 3, 2007
Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE studyT Scott Stroup, Jeffrey A Lieberman, Joseph P McEvoy, et al.
The American Journal of Psychiatry|April 6, 2006
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychoticT Scott Stroup, Jeffrey A Lieberman, Joseph P McEvoy, et al.
Schizophrenia Research|September 21, 2005
Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trialDel D Miller, Joseph P McEvoy, Sonia M Davis, et al.
The American Journal of Psychiatry|March 3, 2007
Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE studyMarvin S Swartz, Diana O Perkins, T Scott Stroup, et al.
Schizophrenia Research|February 9, 2008
Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1Jonathan M Meyer, Vicki G Davis, Donald C Goff, et al.
The American Journal of Psychiatry|December 8, 2006
Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophreniaRobert A Rosenheck, Douglas L Leslie, Jody Sindelar, et al.
American Journal of Preventive Medicine|November 25, 2015
Physical Activity Levels in U.S. Latino/Hispanic Adults: Results From the Hispanic Community Health Study/Study of LatinosElva M Arredondo, Daniela Sotres-Alvarez, Mark Stoutenberg, et al.
Pageof 5